Ensysce Biosciences Inc. (ENSC)
NASDAQ: ENSC
· Real-Time Price · USD
2.47
0.00 (0.00%)
At close: Oct 15, 2025, 3:59 PM
2.47
0.00%
After-hours: Oct 15, 2025, 07:02 PM EDT
Ensysce Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 5.21M | 2.23M | 2.52M | 3.53M |
Cost of Revenue | 7.22M | 7.59M | 19.84M | 151.00 |
Gross Profit | -2.01M | -5.36M | -17.31M | 3.53M |
Operating Income | -6.73M | -10.72M | -24.22M | -19.87M |
Interest Income | n/a | n/a | 1.25M | 3.21M |
Pretax Income | -7.99M | -10.63M | -24.21M | -29.15M |
Net Income | -7.99M | -10.61M | -24.17M | -29.08M |
Selling & General & Admin | 4.72M | 5.36M | 6.91M | 18.71M |
Research & Development | 7.22M | 7.59M | 19.84M | 4.69M |
Other Expenses | -7.22M | -7.59M | -19.84M | -4.69M |
Operating Expenses | 4.72M | 5.36M | 6.91M | 18.71M |
Interest Expense | 1.29M | 353.94K | 109.53K | 1.29M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.94M | 12.95M | 26.75M | 23.4M |
Income Tax Expense | n/a | n/a | n/a | -151 |
Shares Outstanding (Basic) | 1.75M | 2.26M | 179.93K | 84.02K |
Shares Outstanding (Diluted) | 1.75M | 2.26M | 179.93K | 84.02K |
EPS (Basic) | -4.57 | -4.69 | -139.44 | -355.68 |
EPS (Diluted) | -4.57 | -4.69 | -139.44 | -355.68 |
EBITDA | -6.73M | -10.72M | -24.22M | -19.87M |
EBIT | -6.73M | -10.72M | -24.22M | -19.87M |
Depreciation & Amortization | 4.00 | -3 | 151.00 | 151.00 |
Source: Financial Modeling Prep. Financial Sources.